美鼎生物(VIVO)
33.97 0.00 0.0%
| 今开：0.0 | 昨收：33.97 |
| 最高：0.0 | 最低：0.0 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.494957161E9 |
美鼎生物的最新讨论
![[哭泣]](http://js.xueqiu.com/ugc/images/face/emoji_09_cry.png?v=1 "[哭泣]"){kind=small}
用户28964502982022-07-08 16:40
$美鼎生物(VIVO)$ $美鼎生物(VIVO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-22-189072查看全文
牛唐2022-07-08 15:08
韩国SD Biosensor和SJL Partners (Consortium)以15.3亿美元全现金收购$美鼎生物(VIVO)$ 。
$东方生物(SH688298)$ $金域医学(SH603882)$查看全文
美鼎生物的公告
内部交易: $Meridian Bioscience(VIVO)$ 2012-09-10,执行Chairman,MOTTO WILLIAM J ,期权,7988普通股, $2.80
内部交易: $Meridian Bioscience(VIVO)$ 2012-06-06,执行Chairman,MOTTO WILLIAM J ,卖出,3000普通股, $19.50
SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2012-02-14 AccNo: 0001140361-12-008270 Size: 115 KB 网页链接
SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2012-02-15 AccNo: 0001140361-12-008384 Size: 115 KB 网页链接
SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2012-02-14 AccNo: 0000914208-12-000246 Size: 67 KB 网页链接
SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2012-02-13 AccNo: 0001398344-12-000485 Size: 71 KB 网页链接
SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2012-02-10 AccNo: 0000080255-12-000221 Size: 28 KB 网页链接
SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2012-02-10 AccNo: 0001086364-12-001152 Size: 13 KB 网页链接
10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2012-02-09 AccNo: 0001193125-12-048285 Size: 2 MB 网页链接
S-8 - Securities to be offered to employees in employee benefit plans Filed: 2012-02-09 AccNo: 0000892251-12-000026 Size: 110 KB 网页链接